Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA²LEN platform

Publication | 2009

The Galenda project P.-J. Bousquet, P. Demoly,A. Romano, W. Aberer,A. Bircher, M. Blanca, K. Brockow,W. Pichler, M. J. Torres, I. Terreehorst, B. Arnoux, M. Atanaskovic-Markovic, A. Barbaud, A. Bijl, P. Bonadonna, P. G. Burney, S. Caimmi, G. W. Canonica, J. Cernadas, B. Dahlen, J.-P. Daures, J. Fernandez, E. Gomes, J.-L. Gueant, M. L. Kowalski, V. Kvedariene, P.-M. Mertes, P. Martins, E. Nizankowska-Mogilnicka, N. Papadopoulos, C. Ponvert, M. Pirmohamed, J. Ring, M. Salapatas, M. L. Sanz, A. Szczeklik, E. Van Ganse, A. L. De Weck, T. Zuberbier, H. F. Merk, B. Sachs, A. Sidoroff, Global Allergy, Asthma European Network (GA2LEN) and Drug Allergy and Hypersensitivity Database (DAHD) and the European Network for Drug Allergy (ENDA). Allergy (2009), 64:2, doi: 10.1111/j.1398-9995.2008.01944.x

More publications

  • Global Allergy and Asthma European Network (GA²LEN)–a focus for paediatric allergy research

    Publication | 2006
  • Pan-European harmonisation of skin prick testing: GA²LEN study reveals novel sensitisation patterns for inhalant allergens in Europe

    Publication | 2008
  • The CONSORT statement checklist in allergen-specific immunotherapy: a GA²LEN paper

    Publication | 2009
  • The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings.

    Publication | 2008